Unknown PHASE1 INTERVENTIONAL 3-arm NCT01851980

Inhaled Nebulized Furosemide & Physical Activity-Related Breathlessness

Effects of Inhaled Furosemide on Breathlessness During Exercise in the Presence of External Thoracic Restriction: A Dose-Reponse Study

Sponsor: McGill University

Conditions Breathlessness

Interventions CWS Furosemide Placebo

Updated 7 times since 2017 Last updated: Feb 10, 2017 Started: Apr 30, 2016 Primary completion: Apr 30, 2017 Completion: Sep 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01851980, this PHASE1 trial focuses on Breathlessness and remains ongoing. Sponsored by McGill University, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Mar 2019 — Jan 2021 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status
Jun 2018 — Mar 2019 [monthly]

Recruiting PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting PHASE1

First recorded

Apr 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

McGill University

Data source: McGill University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada